Study
Beta-Alanine Supplementation May Boost Muscle Health in Seniors with COPD
A 12-week study showed that beta-alanine increased muscle carnosine by 54%, potentially improving exercise capacity in seniors with COPD.
Summary
In plain language
Researchers have found that taking a daily supplement of beta-alanine for 12 weeks can significantly increase muscle carnosine levels in older adults with Chronic Obstructive Pulmonary Disease (COPD). This increase could help improve muscle endurance, which is often compromised in individuals with COPD. The study noted a 54% rise in muscle carnosine, which is important for reducing muscle fatigue. While the improvement in exercise capacity was not significant, the increase in muscle carnosine is promising. Seniors with COPD might consider discussing the potential benefits of beta-alanine with their healthcare providers to see if it could be a helpful addition to their treatment plan.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study was conducted to explore the effects of beta-alanine supplementation on muscle health in older adults with COPD.
Participants were given a daily dose of beta-alanine or a placebo for 12 weeks. Muscle biopsies and exercise tests were conducted before and after the trial.
The results showed a 54% increase in muscle carnosine levels in those taking beta-alanine, though improvements in exercise capacity were not statistically significant.
While the findings are promising, the study did not find significant changes in exercise performance. More research is needed to confirm these results and determine practical benefits.
Seniors with COPD should consult their healthcare providers to discuss whether beta-alanine is suitable for them.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Beta-Alanine Supplementation May Boost Muscle Health in Seniors with COPD
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study's high score is due to its robust design as a double-blind RCT, which provides strong evidence. However, the lack of detailed allocation concealment and incomplete transparency in reporting slightly reduce its score. The absence of replication evidence and unspecified journal quality also limit the overall score.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 6.7/10 | |
| Statistical methods | 7.5/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This study investigates the effects of 12 weeks of beta-alanine supplementation on muscle carnosine levels and physical capacity in COPD patients. While muscle carnosine increased, no significant improvements in exercise capacity or muscle function were observed.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.